Northern Trust’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
531,628
-312,022
| -37% | -$6.64M | ﹤0.01% | 1995 |
|
|
2025
Q1 | $16.3M | Sell |
843,650
-27,752
| -3% | -$535K | ﹤0.01% | 1754 |
|
|
2024
Q4 | $15.6M | Buy |
871,402
+14,075
| +2% | +$251K | ﹤0.01% | 1853 |
|
|
2024
Q3 | $18.8M | Sell |
857,327
-102,976
| -11% | -$2.26M | ﹤0.01% | 1657 |
|
|
2024
Q2 | $7.49M | Sell |
960,303
-112,411
| -10% | -$877K | ﹤0.01% | 2161 |
|
|
2024
Q1 | $4.44M | Sell |
1,072,714
-35,375
| -3% | -$146K | ﹤0.01% | 2544 |
|
|
2023
Q4 | $2.89M | Buy |
1,108,089
+39,590
| +4% | +$103K | ﹤0.01% | 2797 |
|
|
2023
Q3 | $2M | Buy |
1,068,499
+38,457
| +4% | +$71.9K | ﹤0.01% | 2941 |
|
|
2023
Q2 | $2.59M | Buy |
1,030,042
+963,409
| +1,446% | +$2.42M | ﹤0.01% | 2861 |
|
|
2023
Q1 | $117K | Buy |
66,633
+16,139
| +32% | +$28.2K | ﹤0.01% | 4046 |
|
|
2022
Q4 | $215K | Buy |
50,494
+27,591
| +120% | +$117K | ﹤0.01% | 3833 |
|
|
2022
Q3 | $27K | Buy |
+22,903
| New | +$27K | ﹤0.01% | 4487 |
|
|
2022
Q2 | – | Sell |
-175,682
| Closed | -$431K | – | 4808 |
|
|
2022
Q1 | $431K | Sell |
175,682
-17,120
| -9% | -$42K | ﹤0.01% | 3789 |
|
|
2021
Q4 | $518K | Sell |
192,802
-1,264
| -0.7% | -$3.4K | ﹤0.01% | 3800 |
|
|
2021
Q3 | $972K | Buy |
194,066
+159,811
| +467% | +$800K | ﹤0.01% | 3568 |
|
|
2021
Q2 | $256K | Buy |
+34,255
| New | +$256K | ﹤0.01% | 4043 |
|